Pneumococcal 24-Valent Conjugate Vaccine（Sinovac）
24价肺炎球菌多糖结合疫苗（北京科兴）
Report date: 2026/04/22 20:01:10
Base Information
Drug NamePneumococcal 24-Valent Conjugate Vaccine（Sinovac）
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[6]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesSinovac Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesSinovac Biotech Co LtdSinovac Life Sciences Co Ltd
Inactive CompaniesN/A
Active Indications +[6]
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A